Anavex Life Sciences Corp. (AVXL)
3.66
-0.23
(-5.91%)
USD |
NASDAQ |
Dec 19, 16:00
3.67
+0.01
(+0.27%)
After-Hours: 18:25
Anavex Life Sciences Shareholders Equity (Annual): 94.87M for Sept. 30, 2025
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Vanda Pharmaceuticals, Inc. | 538.55M |
| ADMA Biologics, Inc. | 349.02M |
| Aldeyra Therapeutics, Inc. | 71.00M |
| ACADIA Pharmaceuticals, Inc. | 732.79M |
| CorMedix, Inc. | 84.66M |